Cargando…

Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis

B cell primary thyroid malignant lymphoma (BC-PTML) accounts for 95% of all cases of PTML. However, development of effective treatment and management strategies for BC-PTML is challenging owing to the rarity of this disease. This study assessed data from 1,152 patients in the Surveillance, Epidemiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Shuai, Xie, Lang, You, Yanwei, He, Chengli, Li, Xianghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592747/
https://www.ncbi.nlm.nih.gov/pubmed/36303867
http://dx.doi.org/10.3389/fendo.2022.965448
_version_ 1784814997601255424
author Jin, Shuai
Xie, Lang
You, Yanwei
He, Chengli
Li, Xianghai
author_facet Jin, Shuai
Xie, Lang
You, Yanwei
He, Chengli
Li, Xianghai
author_sort Jin, Shuai
collection PubMed
description B cell primary thyroid malignant lymphoma (BC-PTML) accounts for 95% of all cases of PTML. However, development of effective treatment and management strategies for BC-PTML is challenging owing to the rarity of this disease. This study assessed data from 1,152 patients in the Surveillance, Epidemiology, and End Results (SEER) database who were diagnosed with BC-PTML during 2000–2015. Patients were randomly divided into a training group (n=806) and a test group (n=346) at a ratio of 7:3 using the hold-out method. Kaplan-Meier analysis and log-rank tests were used to calculate the survival rate of patients. Subsequently, a stepwise Cox regression model was established to screen the prognostic factors of patients with BC-PTML, and these variables were used to construct a nomogram to predict 5-, 10-, and 15-year BC-PTML cancer-specific survival (CSS). The discrimination and calibration of the new model were evaluated using the concordance index (C-index) and calibration curves, and the accuracy and benefits of the model were assessed through comparison with the traditional Ann Arbor staging system using decision curve analysis (DCA). After stepwise regression, the optimal model included radiotherapy, primary site surgery, Ann Arbor Stage, chemotherapy, histological subtype, and age at diagnosis. The C-index, area under the receiver operating characteristic curve, and DCA suggested that the nomogram had improved discriminatory ability and clinical benefit compared with the Ann Arbor staging system. In summary, this study established an effective nomogram to predict CSS in patients with BC-PTML and assist clinicians in developing effective individualized treatment strategies.
format Online
Article
Text
id pubmed-9592747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95927472022-10-26 Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis Jin, Shuai Xie, Lang You, Yanwei He, Chengli Li, Xianghai Front Endocrinol (Lausanne) Endocrinology B cell primary thyroid malignant lymphoma (BC-PTML) accounts for 95% of all cases of PTML. However, development of effective treatment and management strategies for BC-PTML is challenging owing to the rarity of this disease. This study assessed data from 1,152 patients in the Surveillance, Epidemiology, and End Results (SEER) database who were diagnosed with BC-PTML during 2000–2015. Patients were randomly divided into a training group (n=806) and a test group (n=346) at a ratio of 7:3 using the hold-out method. Kaplan-Meier analysis and log-rank tests were used to calculate the survival rate of patients. Subsequently, a stepwise Cox regression model was established to screen the prognostic factors of patients with BC-PTML, and these variables were used to construct a nomogram to predict 5-, 10-, and 15-year BC-PTML cancer-specific survival (CSS). The discrimination and calibration of the new model were evaluated using the concordance index (C-index) and calibration curves, and the accuracy and benefits of the model were assessed through comparison with the traditional Ann Arbor staging system using decision curve analysis (DCA). After stepwise regression, the optimal model included radiotherapy, primary site surgery, Ann Arbor Stage, chemotherapy, histological subtype, and age at diagnosis. The C-index, area under the receiver operating characteristic curve, and DCA suggested that the nomogram had improved discriminatory ability and clinical benefit compared with the Ann Arbor staging system. In summary, this study established an effective nomogram to predict CSS in patients with BC-PTML and assist clinicians in developing effective individualized treatment strategies. Frontiers Media S.A. 2022-10-11 /pmc/articles/PMC9592747/ /pubmed/36303867 http://dx.doi.org/10.3389/fendo.2022.965448 Text en Copyright © 2022 Jin, Xie, You, He and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Jin, Shuai
Xie, Lang
You, Yanwei
He, Chengli
Li, Xianghai
Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title_full Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title_fullStr Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title_full_unstemmed Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title_short Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis
title_sort development and validation of a nomogram to predict b-cell primary thyroid malignant lymphoma-specific survival: a population-based analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592747/
https://www.ncbi.nlm.nih.gov/pubmed/36303867
http://dx.doi.org/10.3389/fendo.2022.965448
work_keys_str_mv AT jinshuai developmentandvalidationofanomogramtopredictbcellprimarythyroidmalignantlymphomaspecificsurvivalapopulationbasedanalysis
AT xielang developmentandvalidationofanomogramtopredictbcellprimarythyroidmalignantlymphomaspecificsurvivalapopulationbasedanalysis
AT youyanwei developmentandvalidationofanomogramtopredictbcellprimarythyroidmalignantlymphomaspecificsurvivalapopulationbasedanalysis
AT hechengli developmentandvalidationofanomogramtopredictbcellprimarythyroidmalignantlymphomaspecificsurvivalapopulationbasedanalysis
AT lixianghai developmentandvalidationofanomogramtopredictbcellprimarythyroidmalignantlymphomaspecificsurvivalapopulationbasedanalysis